All news

JPMorgan will arrange a share exchange for Biodexa (BDRX), leaving ordinary shares unchanged.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Biodexa Pharmaceuticals Plc announced a 1-for-8 depositary share exchange for its American Depositary Shares (ADSs), effective around October 26, 2026. This change means one new ADS will represent 400 ordinary shares, up from the previous 50, while the company's ordinary shares themselves remain unaffected. JPMorgan Chase Bank, N.A. will facilitate the mandatory exchange, with no fractional ADSs being allocated.

Read original source

BDRX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.